Yan Wu
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 9
- Oncology top 1%
- Lymphatic System and Diseases 11
- Vascular Tumors and Angiosarcomas 6
- Hematology top 1%
- Molecular Biology top 1%
- Angiogenesis and VEGF in Cancer 33
- Genetics top 1%
-
- Traditional Chinese Medicine Analysis 8
-
- Cardiac Fibrosis and Remodeling 8
-
- Neonatal Respiratory Health Research 7
-
- Cell Adhesion Molecules Research 6
- Co-authors
- Daniel J. HicklinZhenping ZhuLarry WitteSérgio DiasShahin RafiiMalcolm A.S. MooreBeate HeissigKoichi Hattori
- Cited by
- Cancer ResearchOncologyHematology
- Journals
- Journal of Ethnopharmacology (8 papers)Cancer Research (7 papers)Evidence-based Complementary and Alternative Medicine (5 papers)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Yan Wu
121 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 1.7k
- Oncology 2.7k
- Hematology 804
- Molecular Biology 4.6k
- Genetics 669
Countries citing papers authored by Yan Wu
This map shows the geographic impact of Yan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Wu more than expected).
Fields of papers citing papers by Yan Wu
This network shows the impact of papers produced by Yan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Wu. The network helps show where Yan Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yan Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 3 | |
| 8 | 2021 | 6 | |
| 9 | 2018 | 11 | |
| 10 | 2018 | 25 | |
| 11 | 2017 | 18 | |
| 12 | 2017 | 2 | |
| 13 | Type II Cyclic Guanosine Monophosphate-Dependent ProteinKinase Inhibits Vegf-A/Vegfr-2 Pathway Activation In GastricCancer Cells | 2016 | 1 |
| 14 | 2013 | 21 | |
| 15 | 2009 | 40 | |
| 16 | Expression and function of vascular endothelial growth factor receptor–1 in human colon cancer cells | 2004 | 1 |
| 17 | 2004 | 85 | |
| 18 | 2003 | 103 | |
| 19 | Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. | 2002 | 86 |
| 20 | Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthbreakdown → | 2001 | 1479 |
About Yan Wu
Yan Wu is a scholar working on Molecular Biology, Cancer Research, Immunology and Allergy, Complementary and alternative medicine and Oncology, having authored 126 papers that have together received 7.5k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (33 papers), Lymphatic System and Diseases (11 papers), Cancer, Hypoxia, and Metabolism (9 papers), Traditional Chinese Medicine Analysis (8 papers), Cardiac Fibrosis and Remodeling (8 papers), Neonatal Respiratory Health Research (7 papers), Vascular Tumors and Angiosarcomas (6 papers) and Cell Adhesion Molecules Research (6 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (2.7k citations), Hematology (804 citations), Molecular Biology (4.6k citations) and Genetics (669 citations). Yan Wu has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Daniel J. Hicklin, Zhenping Zhu, Larry Witte, Sérgio Dias, Shahin Rafii, Malcolm A.S. Moore, Beate Heissig, Koichi Hattori, Bronislaw Pytowski and Peter Böhlen. Their work appears in journals such as Journal of Ethnopharmacology, Cancer Research, Evidence-based Complementary and Alternative Medicine, Biomedicine & Pharmacotherapy and Stem Cell Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.